|
期刊名称：MOLECULAR DIAGNOSIS & THERAPY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aim & Scope
The journal aims to provide independent and authoritative insights into the latest molecular diagnostic and pharmacogenomic techniques to improve the management of disease in patients in an individualized manner. With a focus on linking diagnostic and prognostic biomarkers to an appropriate therapy, Molecular Diagnosis & Therapy emphasizes the development of companion diagnostic/therapeutic products and the use of pharmacogenomic data in drug development and therapeutic decision-making.
Instructions to Authors
IFA.pdf
Editorial Board
Consulting Editor
- A. Killeen, University of Minnesota, Minneapolis, MN, USA
Editorial Board
- J.S. Bader, Johns Hopkins University, Baltimore, MD, USA
- G. Bianchi, San Raffaele Hospital, Milan, Italy
- C.R. Cantor, Sequenom, San Diego, CA, USA
- D.L. Cooper, David L. Cooper and Associates, Inc. , Madison, WI, USA
- D. Crisan, William Beaumont Hospital, Royal Oak, MI, USA
- L.D. Dikkeschei, Isala Clinics, Zwolle, The Netherlands
- G. Emilien, Universite Catholique de Louvain, Brussels, Belgium
- G. Feldman, Wayne State University School of Medicine, Detroit, MI, USA
- A.G. Frauman, University of Melbourne, Heidelberg VIC, Australia
- R. Gambari, Ferrara University, Ferrara, Italy
- G. S. Ginsburg, Duke University, Durham, NC, USA
- D. Gurwitz, Tel Aviv University, Tel Aviv, Israel
- S. Huang, Eli Lilly & Co, Indianapolis, IN, USA
- M. Ingelman-Sundberg, Karolinska Institute, Stockholm, Sweden
- P.A. Insel, University of California, San Diego, CA, USA
- M.W. Jann, Mercer University, Atlanta, GA, USA
- R.W. Kerwin, Institute of Psychiatry, London, UK
- S.B. Liggett, University of Maryland School of Medicine, Baltimore, MD, USA
- M.W. Linder, University of Louisville School of Medicine, Louisville, KY, USA
- J.J. McCarthy, San Diego State University, San Diego, CA, USA
- U.A. Meyer, University of Basel, Basel, Switzerland
- S. Peroutka, Synergia Pharma, Inc., South San Francisco, CA, USA
- M.J. Ratain, University of Chicago School of Medicine, Chicago, IL, USA
- P.M. Ridker, Brigham and Women's Hospital, Boston, MA, USA
- E. Rohlfs, Genzyme Genetics, Framingham, MA, USA
- W. Sadee, Ohio State University, Columbus, OH, USA
- M.M. Shi, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
- B.M. Silber, Roche Pharmaceutical, Palo Alto, CA, USA
- K.D. Tew, Medical University of South Carolina, Charleston, SC, USA
- F. Thomas, Bioserve Ltd., Brussels, Belgium
- V. Van Deerlin, University of Pennsylvania Health System, Philadelphia, PA, USA
- E.S. Vesell, Pennsylvania State University, Hershey, PA, USA
- D. Viswanatha, University of New Mexico, Albuquerque, NM, USA
- C.L. Vnencak-Jones, Vanderbilt University Medical Center, Nashville, TN, USA
- W.W. Weber, University of Michigan, Ann Arbor, MI, USA
- R.L. Woosley, The Critical Path Institute, Tucson, AZ, USA
- H.-G. Xie, Vanderbilt University School of Medicine, Nashville, TN, USA
|
|
|
|
